| Breakdown | TTM | Feb 2024 | Feb 2024 | Feb 2022 | Feb 2021 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 98.01B | 98.64B | 90.94B | 91.98B | 98.85B | 107.75B |
| Gross Profit | 36.83B | 37.31B | 34.89B | 35.54B | 39.09B | 40.87B |
| EBITDA | 1.07B | 2.32B | 2.32B | 2.31B | 3.85B | 6.52B |
| Net Income | -1.79B | -67.00M | -477.00M | 108.00M | 905.00M | 3.04B |
Balance Sheet | ||||||
| Total Assets | 69.25B | 69.72B | 65.00B | 65.20B | 64.21B | 65.08B |
| Cash, Cash Equivalents and Short-Term Investments | 6.13B | 4.18B | 2.96B | 2.93B | 3.51B | 4.57B |
| Total Debt | 29.36B | 32.35B | 27.48B | 26.74B | 24.61B | 22.07B |
| Total Liabilities | 46.23B | 44.56B | 39.22B | 38.61B | 37.37B | 38.67B |
| Stockholders Equity | 23.02B | 25.16B | 25.78B | 26.59B | 26.83B | 26.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -823.00M | -523.00M | -1.99B | -2.14B | 7.77B |
| Operating Cash Flow | 0.00 | 649.00M | 1.78B | 965.00M | -309.00M | 8.79B |
| Investing Cash Flow | 0.00 | -3.60B | -2.12B | -3.20B | -2.02B | -1.23B |
| Financing Cash Flow | 0.00 | 4.28B | 165.00M | 1.67B | 1.04B | -6.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥330.65B | 8.84 | ― | 1.35% | 15.92% | 52.76% | |
66 Neutral | ¥294.52B | 14.98 | 11.17% | 2.61% | 5.63% | 25.64% | |
65 Neutral | ¥224.13B | 18.16 | ― | 2.23% | 3.24% | 12.49% | |
64 Neutral | ¥451.21B | 9.24 | 4.18% | 2.57% | 1.26% | 14.65% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥254.64B | 19.39 | ― | 2.72% | 2.23% | 57.10% | |
53 Neutral | ¥10.08B | -2.93 | ― | 4.61% | 3.14% | -183.07% |